Published in J Am Soc Nephrol on September 01, 2001
Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat (2009) 1.81
Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am J Pathol (2003) 1.40
LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation. FASEB J (2013) 1.18
Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury. Am J Physiol Renal Physiol (2007) 1.16
TGFbeta-induced RhoA activation and fibronectin production in mesangial cells require caveolae. Am J Physiol Renal Physiol (2008) 1.06
Lysophosphatidic acid and renal fibrosis. Biochim Biophys Acta (2008) 1.04
cAMP and Epac in the regulation of tissue fibrosis. Br J Pharmacol (2012) 1.04
Morphological and proliferative abnormalities in renal mesangial cells lacking RhoGDI. Cell Signal (2009) 1.01
Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Br J Pharmacol (2001) 1.00
Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol (2003) 1.00
High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells. BMC Cell Biol (2007) 0.99
Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion. Int J Cancer (2009) 0.95
A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model. J Vasc Surg (2010) 0.94
Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts. J Invest Dermatol (2008) 0.94
Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis. Kidney Blood Press Res (2008) 0.90
CREB trans-activation of disruptor of telomeric silencing-1 mediates forskolin inhibition of CTGF transcription in mesangial cells. Am J Physiol Renal Physiol (2010) 0.85
Rho kinase inhibition in diabetic kidney disease. Br J Clin Pharmacol (2013) 0.84
In situ expression of connective tissue growth factor in human crescentic glomerulonephritis. Virchows Arch (2004) 0.84
Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis. Mol Pharmacol (2013) 0.83
Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase. Plast Reconstr Surg (2011) 0.82
An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure. Sci Rep (2016) 0.81
Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury. Histochem Cell Biol (2011) 0.80
Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. Mol Endocrinol (2012) 0.78
Proliferation of preosteoblasts on TiO2 nanotubes is FAK/RhoA related. RSC Adv (2015) 0.77
Vectorial secretion of CTGF as a cell-type specific response to LPA and TGF-β in human tubular epithelial cells. Cell Commun Signal (2012) 0.77
Calcitonin induces connective tissue growth factor through ERK1/2 signaling in renal tubular cells. Exp Mol Med (2009) 0.76
The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling. PLoS One (2016) 0.75
Promotion of Ccn2 expression and osteoblastic differentiation by actin polymerization, which is induced by laminar fluid flow stress. J Cell Commun Signal (2012) 0.75
Cell-permeant peptide inhibitors of vasospasm and intimal hyperplasia. Vascular (2012) 0.75
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30
Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton. J Biol Chem (2000) 1.21
Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose. J Am Soc Nephrol (2001) 1.13
Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol (1998) 1.04
Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation (2001) 1.04
Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells. J Biol Chem (1994) 1.04
Control of prostanoid synthesis: role of reincorporation of released precursor fatty acids. Prostaglandins (1986) 1.03
Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Br J Pharmacol (2001) 1.00
Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro. Arthritis Rheum (2001) 1.00
Effects of glucocorticoids on the TPA-induced monocytic differentiation. J Leukoc Biol (1992) 0.97
Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int (1994) 0.97
Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge: differential regulation in the various types of cells in the lung. Am J Pathol (2000) 0.95
Opportunistic and interventional salpingectomy in women at risk: a strategy for preventing pelvic serous cancer (PSC). Eur J Obstet Gynecol Reprod Biol (2013) 0.93
Purification of human leukotriene C4 synthase. Proc Natl Acad Sci U S A (1992) 0.93
Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension (1998) 0.93
An increase in myeloid-related protein serum levels precedes acute renal allograft rejection. J Am Soc Nephrol (2001) 0.90
Altered arachidonic acid metabolism during differentiation of the human monoblastoid cell line U937. Biochim Biophys Acta (1990) 0.89
Glucocorticoid-induced reduction of prostanoid synthesis in TPA-differentiated U937 cells is mainly due to a reduced cyclooxygenase activity. Biochem Pharmacol (1990) 0.89
Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm Res (1998) 0.89
Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts. Kidney Int (2006) 0.87
Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant (1999) 0.86
Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord. J Neuroimmunol (1998) 0.84
Cytosolic phospholipase A2 from human monocytic cells: characterization of substrate specificity and Ca(2+)-dependent membrane association. Biochem J (1993) 0.84
Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M. Kidney Int (1997) 0.83
Cloning and characterization of ZNF236, a glucose-regulated Kruppel-like zinc-finger gene mapping to human chromosome 18q22-q23. Genomics (1999) 0.83
Bacitracin inhibits fibronectin matrix assembly by mesangial cells in high glucose. Kidney Int (2001) 0.83
Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids. J Neurochem (2001) 0.82
Characterization of phospholipase A2 in monocytic cell lines. Functional and biochemical aspects of membrane association. Biochem J (1991) 0.82
Thyroid autoantibodies and associated complications during pregnancy. J Obstet Gynaecol (2010) 0.81
Differentiation-associated expression of prostaglandin G/H synthase in monocytic cells. FEBS Lett (1993) 0.81
Cytokine-induced expression of leukemia inhibitory factor in renal mesangial cells. Kidney Int (1994) 0.81
Modulation of prostaglandin G/H synthase expression in mesangial cells transfected by pp60c-src proto-oncogene. Exp Cell Res (1996) 0.80
Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis. Inflamm Res (2000) 0.79
Alterations in glycosylation and lectin pattern during phorbol ester-induced differentiation of U937 cells. Cancer Res (1990) 0.79
Cooperative and redundant signaling of leukotriene B4 and leukotriene D4 in human monocytes. Allergy (2011) 0.79
Regulation of prostaglandin synthesis in Madin Darby canine kidney cells: role of prostaglandin G/H synthase and secreted phospholipase A2. Biochim Biophys Acta (1996) 0.79
Interference of corticosteroids with prostaglandin E2 synthesis at the level of cyclooxygenase-2 mRNA expression in kidney cells. Biochem Pharmacol (1996) 0.78
A 30-year-old woman with only right-sided asthma? Thorac Cardiovasc Surg (2010) 0.77
Monocytic-endothelial cell interaction: regulation of prostanoid synthesis in human coculture. J Leukoc Biol (1997) 0.77
Modulation of phospholipase D stimulation in c-src transfected mesangial cells. J Lipid Mediat Cell Signal (1997) 0.77
Differential effect of dexamethasone on the regulation of phospholipase A2 and prostanoid synthesis in undifferentiated and phorbolester-differentiated U937 cells. J Cell Biochem (1989) 0.77
Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells. Cytokine (1997) 0.77
Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction. Int J Mol Med (2001) 0.76
Test ordering pattern at the chemical pathology laboratory, hospital universiti sains malaysia. Malays J Med Sci (2003) 0.75
Appendectomy with cytoreductive surgery for ovarian and type 2 endometrial carcinoma. Eur J Gynaecol Oncol (2014) 0.75
Phospholipase A2 activity in T-lymphocytes. FEBS Lett (1986) 0.75
The utilization of an index for serum globulin compensation in diseases associated with decreased serum albumin. Med J Malaysia (2004) 0.75
Sleeve resections for the treatment of non-small cell lung cancer. Minerva Chir (2011) 0.75